Effects of the Ivabradine on Reduction of Inflammatory Markers in Patients With Acute Coronary Syndrome

NCT00815100 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndromes

Interventions

DRUG: Ivabradine
DRUG: Placebo

Sponsor

Hospital Universitario de Canarias